163 related articles for article (PubMed ID: 33779837)
1. The impact of authors' medical specialty on publication patterns and published results of adjuvant radiotherapy for WHO grade 2 meningiomas-a systematic review.
Strand PS; Solheim O
Acta Neurochir (Wien); 2021 Sep; 163(9):2459-2464. PubMed ID: 33779837
[TBL] [Abstract][Full Text] [Related]
2. Gross total resection and adjuvant radiotherapy most significant predictors of improved survival in patients with atypical meningioma.
Rydzewski NR; Lesniak MS; Chandler JP; Kalapurakal JA; Pollom E; Tate MC; Bloch O; Kruser T; Dalal P; Sachdev S
Cancer; 2018 Feb; 124(4):734-742. PubMed ID: 29131312
[TBL] [Abstract][Full Text] [Related]
3. Early adjuvant radiotherapy in the treatment of atypical meningioma.
Jenkinson MD; Waqar M; Farah JO; Farrell M; Barbagallo GM; McManus R; Looby S; Hussey D; Fitzpatrick D; Certo F; Javadpour M
J Clin Neurosci; 2016 Jun; 28():87-92. PubMed ID: 26775147
[TBL] [Abstract][Full Text] [Related]
4. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
Graffeo CS; Leeper HE; Perry A; Uhm JH; Lachance DJ; Brown PD; Ma DJ; Van Gompel JJ; Giannini C; Johnson DR; Raghunathan A
World Neurosurg; 2017 Jul; 103():655-663. PubMed ID: 28450233
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and toxicity of particle radiotherapy in WHO grade II and grade III meningiomas: a systematic review.
Wu A; Jin MC; Meola A; Wong HN; Chang SD
Neurosurg Focus; 2019 Jun; 46(6):E12. PubMed ID: 31153145
[TBL] [Abstract][Full Text] [Related]
6. The role of radiotherapy following gross-total resection of atypical meningiomas.
Komotar RJ; Iorgulescu JB; Raper DM; Holland EC; Beal K; Bilsky MH; Brennan CW; Tabar V; Sherman JH; Yamada Y; Gutin PH
J Neurosurg; 2012 Oct; 117(4):679-86. PubMed ID: 22920955
[TBL] [Abstract][Full Text] [Related]
7. Should adjuvant radiotherapy be used in atypical meningioma (WHO grade 2) following gross total resection? A systematic review and Meta-analysis.
Wujanto C; Chan TY; Soon YY; Vellayappan B
Acta Oncol; 2022 Sep; 61(9):1075-1083. PubMed ID: 36052871
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis.
Chun SW; Kim KM; Kim MS; Kang H; Dho YS; Seo Y; Kim JW; Kim YH; Park CK
Radiat Oncol; 2021 Feb; 16(1):34. PubMed ID: 33596974
[TBL] [Abstract][Full Text] [Related]
9. Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review.
Delgado-López PD; Corrales-García EM
Clin Transl Oncol; 2021 Feb; 23(2):205-221. PubMed ID: 32651886
[TBL] [Abstract][Full Text] [Related]
10. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
11. Survival and Recurrence Outcomes Following Adjuvant Radiotherapy for Grade 2 Intracranial Meningiomas: 13-Year Experience in a Tertiary-Care Center.
Rebchuk AD; Alam A; Hounjet CD; Chaharyn BM; Gooderham PA; Yip S; Ma RMK; Nichol A; Makarenko S
World Neurosurg; 2022 May; 161():e748-e756. PubMed ID: 35240308
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiotherapy for atypical meningiomas.
Bagshaw HP; Burt LM; Jensen RL; Suneja G; Palmer CA; Couldwell WT; Shrieve DC
J Neurosurg; 2017 Jun; 126(6):1822-1828. PubMed ID: 27611201
[TBL] [Abstract][Full Text] [Related]
13. Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma.
Wang C; Kaprealian TB; Suh JH; Kubicky CD; Ciporen JN; Chen Y; Jaboin JJ
Neuro Oncol; 2017 Sep; 19(9):1263-1270. PubMed ID: 28371851
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant radiation for WHO grade II and III intracranial meningiomas: insights on survival and practice patterns from a National Cancer Registry.
Brown DA; Goyal A; Kerezoudis P; Alvi MA; Himes BT; Bydon M; Van Gompel JJ; Chaichana KL; Quiñones-Hinojosa A; Burns TC; Yan E; Parney IF
J Neurooncol; 2020 Sep; 149(2):293-303. PubMed ID: 32860156
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Clinical Efficacy of Adjuvant Radiotherapy for World Health Organization Grade II Intracranial Meningioma.
Palmieri M; Armocida D; De Pietro R; Chiarello G; Rizzo F; Garbossa D; Marampon F; Santoro A; Frati A
World Neurosurg; 2023 Jul; 175():e1117-e1123. PubMed ID: 37088414
[TBL] [Abstract][Full Text] [Related]
17. Major complications from radiotherapy following treatment for atypical meningiomas.
Dawley T; Rana Z; Abou-Al-Shaar H; Goenka A; Schulder M
Neurosurg Focus; 2019 Jun; 46(6):E5. PubMed ID: 31153147
[TBL] [Abstract][Full Text] [Related]
18. Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis.
Stessin AM; Schwartz A; Judanin G; Pannullo SC; Boockvar JA; Schwartz TH; Stieg PE; Wernicke AG
J Neurosurg; 2012 Oct; 117(4):669-75. PubMed ID: 22900840
[TBL] [Abstract][Full Text] [Related]
19. Atypical meningiomas: is postoperative radiotherapy indicated?
Lee KD; DePowell JJ; Air EL; Dwivedi AK; Kendler A; McPherson CM
Neurosurg Focus; 2013 Dec; 35(6):E15. PubMed ID: 24289123
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of adjuvant radiotherapy for intracranial atypical and malignant meningiomas.
Unterberger A; Nguyen T; Duong C; Kondajji A; Kulinich D; Yang I
J Neurooncol; 2021 Apr; 152(2):205-216. PubMed ID: 33635510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
